Efficacy and Safety of Gefapixant for Refractory or Unexplained Chronic Cough over 52 Weeks.
American journal of respiratory and critical care medicine(2023)
摘要
"Efficacy and Safety of Gefapixant for Refractory or Unexplained Chronic Cough Over 52 Weeks ." American Journal of Respiratory and Critical Care Medicine, 0(ja), pp.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要